5,028 Shares in Aflac Incorporated (NYSE:AFL) Acquired by Curat Global LLC

Curat Global LLC purchased a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 5,028 shares of the financial services provider's stock, valued at approximately $559,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Foster Group Inc. bought a new position in shares of Aflac during the 1st quarter valued at $241,000. Armstrong Fleming & Moore Inc bought a new position in shares of Aflac during the 1st quarter valued at $442,000. Vest Financial LLC lifted its holdings in shares of Aflac by 6.8% during the 1st quarter. Vest Financial LLC now owns 882,211 shares of the financial services provider's stock valued at $98,093,000 after buying an additional 55,863 shares during the period. West Coast Financial LLC lifted its holdings in shares of Aflac by 3.0% during the 1st quarter. West Coast Financial LLC now owns 6,124 shares of the financial services provider's stock valued at $681,000 after buying an additional 180 shares during the period. Finally, Chesley Taft & Associates LLC lifted its holdings in shares of Aflac by 5.3% during the 1st quarter. Chesley Taft & Associates LLC now owns 19,892 shares of the financial services provider's stock valued at $2,212,000 after buying an additional 998 shares during the period. 67.44% of the stock is owned by institutional investors.

Aflac Trading Up 1.5%

NYSE AFL traded up $1.50 during trading hours on Friday, hitting $103.71. 2,035,431 shares of the company were exchanged, compared to its average volume of 2,108,071. The stock has a 50-day moving average price of $105.39 and a 200 day moving average price of $105.95. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 52 week low of $86.46 and a 52 week high of $115.50. The stock has a market cap of $56.07 billion, a PE ratio of 10.80, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 16.20% and a net margin of 28.76%. The company had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. During the same period in the previous year, the firm earned $1.66 earnings per share. The company's revenue was down 37.5% compared to the same quarter last year. Analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were given a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Wells Fargo & Company raised their target price on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 6th. Barclays raised their target price on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a report on Thursday, May 1st. Piper Sandler raised their target price on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. increased their price target on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Morgan Stanley increased their price target on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Aflac currently has an average rating of "Hold" and a consensus price target of $104.93.

Insider Buying and Selling at Aflac

In related news, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the sale, the director now owns 6,728 shares in the company, valued at approximately $711,149.60. The trade was a 29.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director now owns 70,992 shares of the company's stock, valued at $7,496,045.28. The trade was a 34.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 70,552 shares of company stock worth $7,501,752 over the last 90 days. Company insiders own 0.90% of the company's stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.